| A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis TE King Jr, WZ Bradford, S Castro-Bernardini, EA Fagan, I Glaspole, ... New England journal of medicine 370 (22), 2083-2092, 2014 | 3751 | 2014 |
| Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline G Raghu, M Remy-Jardin, JL Myers, L Richeldi, CJ Ryerson, DJ Lederer, ... American journal of respiratory and critical care medicine 198 (5), e44-e68, 2018 | 3091 | 2018 |
| Nintedanib in progressive fibrosing interstitial lung diseases KR Flaherty, AU Wells, V Cottin, A Devaraj, SLF Walsh, Y Inoue, ... New England Journal of Medicine 381 (18), 1718-1727, 2019 | 1722 | 2019 |
| Short telomeres are a risk factor for idiopathic pulmonary fibrosis JK Alder, JJL Chen, L Lancaster, S Danoff, S Su, JD Cogan, I Vulto, M Xie, ... Proceedings of the National Academy of Sciences 105 (35), 13051-13056, 2008 | 879 | 2008 |
| Diagnosis of hypersensitivity pneumonitis in adults: an official ATS/JRS/ALAT clinical practice guideline G Raghu, M Remy-Jardin, CJ Ryerson, JL Myers, M Kreuter, M Vasakova, ... American journal of respiratory and critical care medicine 202 (3), e36-e69, 2020 | 681 | 2020 |
| European respiratory society, Japanese respiratory society, and latin American thoracic society. Diagnosis of idiopathic pulmonary fibrosis. An official ATS G Raghu, M Remy-Jardin, JL Myers, L Richeldi, CJ Ryerson, DJ Lederer ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2018 198 …, 2018 | 499* | 2018 |
| Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? GR Connors, L Christopher-Stine, CV Oddis, SK Danoff Chest 138 (6), 1464-1474, 2010 | 485 | 2010 |
| Cyclic AMP-dependent phosphorylation of a brain inositol trisphosphate receptor decreases its release of calcium. S Supattapone, SK Danoff, A Theibert, SK Joseph, J Steiner, SH Snyder Proceedings of the National Academy of Sciences 85 (22), 8747-8750, 1988 | 471 | 1988 |
| Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised … AU Wells, KR Flaherty, KK Brown, Y Inoue, A Devaraj, L Richeldi, T Moua, ... The lancet Respiratory medicine 8 (5), 453-460, 2020 | 435 | 2020 |
| Pneumonitis in non–small cell lung cancer patients receiving immune checkpoint immunotherapy: incidence and risk factors K Suresh, KR Voong, B Shankar, PM Forde, DS Ettinger, KA Marrone, ... Journal of Thoracic Oncology 13 (12), 1930-1939, 2018 | 349 | 2018 |
| Three additional inositol 1, 4, 5-trisphosphate receptors: molecular cloning and differential localization in brain and peripheral tissues. CA Ross, SK Danoff, MJ Schell, SH Snyder, A Ullrich Proceedings of the National Academy of Sciences 89 (10), 4265-4269, 1992 | 329 | 1992 |
| Management of interstitial lung disease associated with connective tissue disease SC Mathai, SK Danoff Bmj 352, 2016 | 320 | 2016 |
| Inositol 1, 4, 5-trisphosphate receptors: distinct neuronal and nonneuronal forms derived by alternative splicing differ in phosphorylation. SK Danoff, CD Ferris, C Donath, GA Fischer, S Munemitsu, A Ullrich, ... Proceedings of the National Academy of Sciences 88 (7), 2951-2955, 1991 | 319 | 1991 |
| Immune checkpoint immunotherapy for non-small cell lung cancer: benefits and pulmonary toxicities K Suresh, J Naidoo, CT Lin, S Danoff Chest 154 (6), 1416-1423, 2018 | 301 | 2018 |
| Anti–melanoma differentiation–associated protein 5–associated dermatomyositis: expanding the clinical spectrum JC Hall, L Casciola‐Rosen, LA Samedy, J Werner, K Owoyemi, SK Danoff, ... Arthritis care & research 65 (8), 1307-1315, 2013 | 296 | 2013 |
| Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial MR Horton, V Santopietro, L Mathew, KM Horton, AJ Polito, MC Liu, ... Annals of internal medicine 157 (6), 398-406, 2012 | 239 | 2012 |
| 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis … R Aggarwal, LG Rider, N Ruperto, N Bayat, B Erman, BM Feldman, ... Arthritis & Rheumatology 69 (5), 898-910, 2017 | 225 | 2017 |
| Characterization of a membrane protein from brain mediating the inhibition of inositol 1, 4, 5-trisphosphate receptor binding by calcium SK Danoff, S Supattapone, SH Snyder Biochemical Journal 254 (3), 701-705, 1988 | 218 | 1988 |
| A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 … I Pinal-Fernandez, M Casal-Dominguez, JA Huapaya, J Albayda, JJ Paik, ... Rheumatology 56 (6), 999-1007, 2017 | 211 | 2017 |
| Clinical profile of anti-PL-12 autoantibody: cohort study and review of the literature M Kalluri, SA Sahn, CV Oddis, SL Gharib, L Christopher-Stine, SK Danoff, ... Chest 135 (6), 1550-1556, 2009 | 204 | 2009 |
